Login | Users Online: 570  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
 


 
GHA PAGE
Year : 2006  |  Volume : 7  |  Issue : 1  |  Page : 39-40 Table of Contents     

Gulf RACE - 2006 : A new era in disease documentation in the Gulf and the Middle East


MB, ChB, FRCPC, FACC, FGHA,

Date of Web Publication17-Jun-2010

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Zubaid M. Gulf RACE - 2006 : A new era in disease documentation in the Gulf and the Middle East. Heart Views 2006;7:39-40

How to cite this URL:
Zubaid M. Gulf RACE - 2006 : A new era in disease documentation in the Gulf and the Middle East. Heart Views [serial online] 2006 [cited 2020 Sep 21];7:39-40. Available from: http://www.heartviews.org/text.asp?2006/7/1/39/63919

GULF RACE-2006 is the start of a long-awaited acute coronary syndromes registry across the Arabian Gulf states.

When the Gulf Heart Association (GHA) was established in January 2001, one of its aims was to be the source of reference for cardiac diseases (to the Ministries of Health) in the Arabian Gulf countries. The founding members realized that for the GHA to be the leading source of reference, they needed to have data about cardiac diseases in the Gulf. They also realized that their individual countries lacked crucial information about heart diseases. Therefore, the GHA embarked on establishing several programs to study the patterns of cardiac diseases and the treatment practices in the Gulf countries. It was felt that this would be best achieved through disease registries.

The GHA took into consideration several factors in order to decide which cardiac disease to study first. The first factor was the World Health Organizations's (WHO) predictions for cardiovascular diseases to be the leading cause of morbidity and mortality in the developing countries by the year 2020 [1],[2],[3],[4] . The second factor was the high prevelance of certain risk factors in the Gulf countries. Studies have shown a high prevalence rate of type 2 diabetes the adult populations (15-18%), obesity, and smoking [5],[6],[7],[8],[9] . Therefore, based on WHO's predictions and the high prevelance of cardiac risk factors, the GHA chose acute coronary syndromes (ACS) to be the first cardiac disease to be formally studied.

Individual Gulf countries had their own established hospital or country registries of ACS. However, it was decided that ACS should be studied in a uniform Registry across the Gulf countries. It was also determined that the Registry should reflect the true practice across each country and should not only represent the practice in a handful of highly equipped tertiary care centres.

To that end, the GHA Governing Board formed an ACS Committee on September 22, 2005 while meeting in Dubai, UAE. The main task of the Committee was to establish an ACS Registry. The Committee members took that task seriously and developed a draft protocol which was later reviewed and modified several times. The GHA ACS Committee held it's first meeting in Doha, Qatar on December 29, 2005 to critically undertake a major review of the draft protocol. The protocol was later reviewed and ratified by the GHA Governing Board on April 8, 2006 in Manama, Kingdom of Bahrain.

The GHA ACS Committee formed an administrative infrastructure to insure the proper implementation of this Registry. It was named Gulf Registry of Acute Coronary Events - 2006, under the acronym Gulf RACE - 2006. Two stand-alone investigators meetings were held in preparation for the implementation of the Registry. The first one was held in Dubai on April 13, 2006 for the Oman and UAE investigators. The second meeting was held in Kuwait on April 20 for the Kuwait, Bahrain and Qatar investigators. The data collection forms and the protocol underwent final changes after both meetings and the date of May 8, 2006 was chosen to be the start date for the one-month pilot phase.

The aims of the Gulf RACE - 2006 are:

  1. Estimate the incidence of ACS in the Gulf.
  2. Analyze the practice patterns and treatments of ACS in the Gulf countries.
  3. Determine the adherence to published guidelines.
  4. Study all elements of this registry and compare them among the individual countries. Specific elements of the registry that will be analyzed, to mention some, include the distribution of the different risk factors, the types of myocardial infarctions, the incidence of unstable angina, the use of thrombolysis and other drugs in-hospital and at discharge, and morbidity/mortality rates.
  5. To carry out the same registry periodically every few years in order to find out changes in our practice and the influence of new therapy on our practice and results.
  6. Establish a collaborative network group among members of the registry. This collaboration will result in an infrastructure that will be used in the future for other types of registries or trials.
Enrollment in Gulf RACE - 2006 started on May 8, 2006 across 46 hospitals in the Sultanate of Oman, United Arab Emirates, Qatar, Kingdom of Bahrain, and Kuwait. We have obtained ethics approval from representative bodies in the 5 countries. By enrolling 46 hospitals, the Registry will cover more than 95% of the population in these 5 countries.


   Acknowledgements Top


The GHA would like to thank Sanofi Aventis for their support of Gulf RACE - 2006. Sanofi aventis has provided unconditional and unrestricted grant for the undertaking of Gulf RACE - 2006.

 
   References Top

1.WHO. The World Health Report 1998. WHO, Geneva, 1998, p 48-185.   Back to cited text no. 1      
2.Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4: 1241-1243.   Back to cited text no. 2      
3.Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. The Lancet 2002; 360:1347-1360.   Back to cited text no. 3      
4.Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.   Back to cited text no. 4      
5.Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj K. Known type 2 diabetes among the Kuwaiti population: A prevalence study. Acta Diabetol 1996; 33(2): 145-149.   Back to cited text no. 5      
6.Abdella N, Al-Arouj M, Al-Nakhi A, Al-Assoussi A, Moussa M. Non-insulin dependent diabetes in Kuwait: Prevalence rates and associated risk factors. Diabetes Res Clin Pract 1998; 42(3): 187-196.   Back to cited text no. 6      
7.Al-Isa AN. Changes in body mass index (BMI) and prevalence of obesity among Kuwaitis 1980-1994. International Journal of Obesity. 1997a; 21: 1093-1099.   Back to cited text no. 7      
8.Al-Isa AN. Temporal changes in body mass index and prevalence of obesity among Kuwaiti men. Ann Nutr Metab. 1997b; 41(5): 307-314.   Back to cited text no. 8      
9.Memon A, Moody PM, Sugathan TN, El-Gerges N, Al-Bustan M, Al-Shatti A, Al-Jazzaf H. Epidemiology of smoking among Kuwaiti adults: Prevalence, characteristics, and attitudes. Bulletin of the World Health Organization. 2000; 78: 1306-1315.  Back to cited text no. 9      




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Acknowledgements
    References

 Article Access Statistics
    Viewed872    
    Printed39    
    Emailed0    
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal